Healthcare provider profile · identity verified

Michael J Ruff, MD

Family Practice · SPRINGBORO, OH · NPI 1124084454

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	478	133
Levothyroxine Sodium	Levothyroxine Sodium	284	75
Lisinopril	Lisinopril	279	75
Omeprazole	Omeprazole	230	63
Amlodipine Besylate	Amlodipine Besylate	204	65
Losartan Potassium	Losartan Potassium	175	49
Metformin Hcl	Metformin Hcl	173	48
Rosuvastatin Calcium	Rosuvastatin Calcium	163	48
Gabapentin	Gabapentin	141	30
Metoprolol Succinate	Metoprolol Succinate	128	44
Tamsulosin Hcl	Tamsulosin Hcl	125	35
Furosemide	Furosemide	118	31
Hydrochlorothiazide	Hydrochlorothiazide	118	38
Pravastatin Sodium	Pravastatin Sodium	113	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	111	31
Sertraline Hcl	Sertraline Hcl	109	28
Trazodone Hcl	Trazodone Hcl	106	28
Alprazolam	Alprazolam	104	22
Tramadol Hcl	Tramadol Hcl	101	28
Metoprolol Tartrate	Metoprolol Tartrate	99	31
Simvastatin	Simvastatin	93	29
Clonazepam	Clonazepam	89	18
Pantoprazole Sodium	Pantoprazole Sodium	81	26
Carvedilol	Carvedilol	76	19
Albuterol Sulfate Hfa	Albuterol Sulfate	73	29
Potassium Chloride	Potassium Chloride	73	22
Lorazepam	Lorazepam	70	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	69	23
Jardiance	Empagliflozin	66	15
Eliquis	Apixaban	65	13
Montelukast Sodium	Montelukast Sodium	65	17
Amoxicillin	Amoxicillin	63	48
Azithromycin	Azithromycin	60	55
Famotidine	Famotidine	53	19
Pioglitazone Hcl	Pioglitazone Hcl	52	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	48	suppressed
Prednisone	Prednisone	46	33
Synthroid	Levothyroxine Sodium	46	15
Zolpidem Tartrate	Zolpidem Tartrate	46	15
Allopurinol	Allopurinol	44	13
Meloxicam	Meloxicam	44	15
Atenolol	Atenolol	43	13
Citalopram Hbr	Citalopram Hydrobromide	43	13
Buspirone Hcl	Buspirone Hcl	41	suppressed
Methocarbamol	Methocarbamol	41	12
Venlafaxine Hcl Er	Venlafaxine Hcl	40	12
Methylprednisolone	Methylprednisolone	38	32
Metformin Hcl Er	Metformin Hcl	37	suppressed
Mirtazapine	Mirtazapine	36	11
Ozempic	Semaglutide	35	12
Finasteride	Finasteride	33	suppressed
Tizanidine Hcl	Tizanidine Hcl	33	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	11
Ibuprofen	Ibuprofen	30	11
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Fluticasone Propionate	Fluticasone Propionate	29	11
Alendronate Sodium	Alendronate Sodium	28	12
Valsartan	Valsartan	28	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	27	11
Glipizide Er	Glipizide	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Cefuroxime	Cefuroxime Axetil	25	21
Naproxen	Naproxen	25	suppressed
Azelastine Hcl	Azelastine Hcl	24	14
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Colestipol Hcl	Colestipol Hcl	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Indapamide	Indapamide	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Invokana	Canagliflozin	17	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	15
Tradjenta	Linagliptin	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Temazepam	Temazepam	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Glipizide	Glipizide	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Vilazodone Hcl	Vilazodone Hcl	12	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Duloxetine Hcl	Duloxetine Hcl	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Ramipril	Ramipril	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error